Cole Lab
The Cole Lab is focused on advancing the treatment and management of patients in need of mechanical circulatory support, including both long-term and temporary devices.
Personal Statement
I am currently the associate director of Mechanical Circulatory Support (MCS) research and education at the Cedars-Sinai Smidt Heart Institute, where I am actively involved in heart failure and mechanical circulatory support research. My research focus is predominantly on temporary and durable mechanical circulatory support devices for advanced heart failure, particularly their indications/outcomes, as well as management of cardiogenic shock. I am also involved in several ongoing trials evaluating the etiology, diagnosis and management of congestive heart failure and cardiomyopathy.
Robert Cole
Breakthrough Research
- This rapidly growing field deals with advanced options for cardiovascular support using temporary MCS devices, including ECMO, Impellas, intra-aortic balloon pumps and various other forms of intravascular and extracorporeal support systems. I have studied the outcomes and hemodynamic roles resulting from the use of these devices in end stage heart failure and cardiogenic shock.
- The total artificial heart represents the only definitive mechanical therapy for severe, end-stage biventricular heart failure. Its complexities in selection, outcomes and adverse events limit its use to a few medical centers worldwide. I have extensive experience in the utilization and management of these devices and continue to investigate their role in the management of patients.
Collaborations
The Cole Lab collaborates with a wide range of investigators within Cedars-Sinai and institutions around the world.